How Federal Cannabis Reform Could Create Billions in New Tax Revenue and Give Washington Another Tool to Fight The Growing U.S. Budget Deficit
Washington has a lot of problems when it comes to the federal budget and this week the current admission is proposing adding roughly $1 trillion more. But could marijuana rescheduling help reduce the spiraling national deficit? When the administration took office in January 2025, the debt was roughly $36.2 trillion and it has now crossed over $40 trillion in roughly 1.5 years.
The United States is projected to run a $1.9 trillion federal budget deficit in fiscal year 2026, according to the Congressional Budget Office. Federal spending is expected to reach $7.4 trillion, compared with $5.6 trillion in revenue. The deficit is projected to grow to $3.1 trillion by 2036. Or even higher if recent administration pledges are acted upon.
RELATED: New York and Texas Take Opposite Paths on Cannabis, CBD and Hemp
Against numbers this large, cannabis tax revenue might look like a rounding error. But the marijuana industry is already demonstrating its ability to generate substantial tax dollars—and federal reform could create a much larger economic opportunity.
States with legal adult-use cannabis markets collected more than $4.57 billion in marijuana taxes in 2025 alone, according to the Marijuana Policy Project. Since legal recreational sales began in Colorado and Washington in 2014, states have collected more than $28.4 billion in cannabis tax revenue.
The federal opportunity begins with rescheduling.
In April 2026, the Treasury Department and IRS announced plans for new tax guidance following a Justice Department order placing certain state-licensed medical marijuana products and activities into Schedule III, while leaving unlicensed marijuana and bulk marijuana in Schedule I.
One major consequence involves Section 280E of the federal tax code. Currently, marijuana businesses subject to the provision cannot deduct many ordinary business expenses because cannabis remains classified as a Schedule I or II controlled substance. Moving qualifying cannabis activity to Schedule III generally removes the restriction.
The change, however, does not necessarily mean more federal tax revenue. In fact, allowing cannabis companies to deduct normal expenses could initially reduce their tax bills. The bigger opportunity comes if Congress ultimately paired rescheduling with a federal cannabis excise tax and a broader regulatory framework. A national system could bring more businesses into the legal economy, create a new federal tax base and potentially reduce the size of the illicit market.
RELATED: What Does Scientology Say About Marijuana And Fun
Even $10 billion a year in new federal cannabis-related revenue would represent only about half of one percent of today’s federal deficit. It would not come close to solving Washington’s fiscal problem.
But $10 billion is still $10 billion.
With the national debt climbing, Washington is going to need to examine every realistic source of revenue and economic growth. Cannabis will not balance the federal budget, but a regulated national marijuana industry could eventually become a meaningful contributor to federal revenues—and one of the few new industries capable of generating billions in tax dollars from an already established consumer market.
